SANTA CLARA, Calif.–(BUSINESS WIRE)–Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, today announced that results from the KAST pivotal trial have been published online in the journal Spine. KAST showed that the Kiva® VCF Treatment System, a novel

Related posts:

  1. Benvenue launches Kiva VCF, unveils results from KAST trial
  2. Benvenue Medical Begins Enrollment in Landmark Study Versus Balloon Kyphoplasty
  3. INDEPENDENT STUDY DEMONSTRATES CLINICAL ADVANTAGES OF KIVA® OVER BALLOON KYPHOPLASTY
Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone